You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vildagliptin

Showing 1 - 25 of 220
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes Trial in Damanhur (Vildagliptin 50 MG, Glimepiride 3 Mg Oral Tablet)

Recruiting
  • Type 2 Diabetes
  • Vildagliptin 50 MG
  • Glimepiride 3 Mg Oral Tablet
  • Damanhūr, Elbehairah, Egypt
    Damanhour Teaching Hospital, General Organization for Teaching H
Sep 29, 2023

Poly Cystic Ovary Syndrome Trial in Giza (Metformin Hydrochloride tablet, Vildagliptin 50 MG)

Recruiting
  • Poly Cystic Ovary Syndrome
  • Metformin Hydrochloride tablet
  • Vildagliptin 50 MG
  • Giza, Egypt
    October 6 university hospital
Nov 26, 2023

Fed Conditions Trial in Tunis (Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg) (Galvumet®), Metformin /

Completed
  • Fed Conditions
  • Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg) (Galvumet®)
  • Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg)
  • Tunis, Tunisia
    Centre National Chalbi Belkahia de Pharmacovogilance
Oct 13, 2023

Fed Conditions Trial in Bab Souika (Metformin / Vildagliptin Film Coated Tablets (850 mg / 50 mg), Galvumet® Film Coated Tablets

Completed
  • Fed Conditions
  • Metformin / Vildagliptin Film Coated Tablets (850 mg / 50 mg)
  • Galvumet® Film Coated Tablets (850 mg / 50 mg)
  • Bab Souika, Tunise, Tunisia
    Centre National Chalbi Belkahia de Pharmacovogilance
Oct 22, 2023

Type 2 Diabetes Trial in Karachi (Empagliflozin, Vildagliptin)

Completed
  • Type 2 Diabetes
  • Karachi, Sindh, Pakistan
    Department of Diabetes and Endocrinology at Sindh Government Hos
Apr 28, 2022

Schizophrenia, Dyslipidemias Trial in Shibin Al Kawm (Vildagliptin 50 MG, Placebo)

Recruiting
  • Schizophrenia
  • Dyslipidemias
  • Vildagliptin 50 MG
  • Placebo
  • Shibīn Al Kawm, Menoufia, Egypt
    Faculty of Pharmacy
Feb 8, 2022

Disorder Related to Renal Transplantation, Diabetes Trial in Besançon (Vildagliptin, Placebo)

Recruiting
  • Disorder Related to Renal Transplantation
  • Diabetes
  • Vildagliptin
  • Placebo
  • Besançon, France
    CHU de Besançon
Aug 1, 2022

Diabetes Trial (Vildagliptin 50 MG)

Completed
  • Diabetes Mellitus
  • Vildagliptin 50 MG
  • (no location specified)
Apr 14, 2022

Fatty Liver, Nonalcoholic, Diabetes, Type 2 Trial in Alexandria (Metformin)

Active, not recruiting
  • Fatty Liver, Nonalcoholic
  • Diabetes Mellitus, Type 2
  • Alexandria, Egypt
    Alexandria University.
Jan 14, 2022

To Determine Bioequivalence Under Fed Conditions Trial (Metformin and Vildagliptin 850/50 mg)

Completed
  • To Determine Bioequivalence Under Fed Conditions
  • Metformin and Vildagliptin 850/50 mg
  • (no location specified)
Apr 16, 2022

To Determine Bioequivalence Under Fed Conditions Trial (Metformin and Vildagliptin 1000/50 mg)

Completed
  • To Determine Bioequivalence Under Fed Conditions
  • Metformin and Vildagliptin 1000/50 mg
  • (no location specified)
Apr 14, 2022

Cognitive Protective Effect of Newer Antidiabetic Drugs

Recruiting
  • Type 2 Diabetes
  • Alexandria, Egypt
    Alexandria University
Jul 24, 2022

Type 2 Diabetes Trial in Mexico (Glimepiride / Vildagliptin / Metformin (2 mg/ 50 mg/ 1000 mg), Glimepiride / Vildagliptin /

Not yet recruiting
  • Type 2 Diabetes
  • Glimepiride / Vildagliptin / Metformin (2 mg/ 50 mg/ 1000 mg)
  • Glimepiride / Vildagliptin / Metformin (4 mg/ 50 mg/ 1000 mg)
  • Cancún, Quintana Roo, Mexico
  • +4 more
Jun 8, 2021

Diabetes, Type 2 Trial in Shinjuku-Ku (Imeglimin, Metformin, Vildagliptin)

Recruiting
  • Diabetes Mellitus, Type 2
  • Shinjuku-Ku, Tokyo, Japan
    Center Hospital of the National Center for Global Health and Med
Sep 26, 2022

Diabetes, Type 2 Trial in Minya (Vildagliptin 50 MG, Sitagliptin 100mg, MetFORMIN 1000 Mg Oral Tablet)

Completed
  • Diabetes Mellitus, Type 2
  • Vildagliptin 50 MG
  • +2 more
  • Minya, Egypt
    Minya University Hospital
Jun 4, 2021

Metformin and DPP4 Inhibitors on Cognition and Cardiovascular

Recruiting
  • Type 2 Diabetes Mellitus
  • Vildagliptin
  • Cairo, Al Kasr Al Aini, Egypt
    National Institute of diabetes and endocrinology
Jun 19, 2022

Renal Impairment, Diabetes Trial in Moscow (Vildagliptin)

Completed
  • Renal Impairment
  • Diabetes
  • Vildagliptin
  • Moscow, Russian Federation
    Novartis Investigator Site
Dec 11, 2020

Thyroid Cancer Trial

Completed
  • Thyroid Cancer
    • (no location specified)
    Jul 2, 2021

    Type 2 Diabetes Trial in Tokyo (Vildagliptin (LAF237), Voglibose, Vildagliptin and Voglibose)

    Completed
    • Type 2 Diabetes
    • Vildagliptin (LAF237)
    • +2 more
    • Tokyo, Japan
      Novartis Investigative Site
    Dec 16, 2020

    Diabetes, Type 2 Trial in Baltimore (Vildagliptin)

    Terminated
    • Diabetes Mellitus, Type 2
    • Vildagliptin
    • Baltimore, Maryland
      Novartis Investigator Site
    Dec 11, 2020

    Diabetes, Type 2 Trial in East Hanover, Nurnberg (vildagliptin, glimepiride, Metformin)

    Completed
    • Diabetes Mellitus, Type 2
    • vildagliptin
    • +4 more
    • East Hanover, New Jersey
    • +1 more
    Dec 11, 2020

    Diabetes, Type 2 Trial in East Hanover, Multiple Locations (Vildagliptin, Metformin, Vildagliptin + Metformin)

    Completed
    • Diabetes Mellitus, Type 2
    • Vildagliptin
    • +2 more
    • East Hanover, New Jersey
    • +1 more
    Dec 11, 2020

    Diabetes, Type 2 Trial in Nurnberg, Basel (vildagliptin, Gliclazide, Metformin)

    Completed
    • Diabetes Mellitus, Type 2
    • vildagliptin
    • +2 more
    • Nurnberg, Germany
    • +1 more
    Dec 11, 2020

    Diabetes, Type 2 Trial in Basel (vildagliptin, )

    Completed
    • Diabetes Mellitus, Type 2
    • vildagliptin
    • placebo
    • Basel, Switzerland
      Novartis Pharmaceuticals
    Dec 11, 2020

    Diabetes, Type 2 Trial in East Hanover (Vildagliptin, pioglitazone, Placebo)

    Completed
    • Diabetes Mellitus, Type 2
    • Vildagliptin
    • +2 more
    • East Hanover, New Jersey
      Novartis Pharmaceuticals
    Dec 11, 2020